Evidence map›Paper›PMID 32123074›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2020

Abrogation of esophageal carcinoma development in miR-31 knockout rats.

Louise Y Fong, Cristian Taccioli, Alexey Palamarchuk, Guidantonio Malagoli Tagliazucchi, Ruiyan Jing, Karl J Smalley, Sili Fan, Joseph Altemus, Oliver Fiehn, Kay Huebner and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.8field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Article
  3. Circulating long non-coding RNANon-coding RNA research · 2024
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Zinc treatment reverses and anti-Zn-regulated miRs suppress esophageal carcinomas in vivo.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Louise Y FongDepartment of Pathology, Anatomy, and Cell Biology, Thomas Jefferson University, Philadelphia, PA 19107; louise.fong@jefferson.edu carlo.croce@osumc.edu.
Cristian TaccioliDepartment of Animal Medicine, Production and Health, University of Padova, 35020 Legnaro (PD), Italy.ORCID 0000-0003-2995-5612
Alexey PalamarchukDepartment of Cancer Biology and Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210.
Guidantonio Malagoli TagliazucchiDivision of Cardiology, Azienda Ospedaliero-Universitaria di Parma, 43126 Parma, Italy.
Ruiyan JingDepartment of Pathology, Anatomy, and Cell Biology, Thomas Jefferson University, Philadelphia, PA 19107.
Karl J SmalleySidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107.ORCID 0000-0003-1502-6759
Sili FanNIH West Coast Metabolomics Center, UC Davis Genome Center, University of California, Davis, CA 95616.
Joseph AltemusOffice of Animal Resources, Thomas Jefferson University, Philadelphia, PA 19107.ORCID 0000-0002-9954-3819
Oliver FiehnNIH West Coast Metabolomics Center, UC Davis Genome Center, University of California, Davis, CA 95616.ORCID 0000-0002-6261-8928
Kay HuebnerDepartment of Cancer Biology and Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210.
John L FarberDepartment of Pathology, Anatomy, and Cell Biology, Thomas Jefferson University, Philadelphia, PA 19107.
Carlo M CroceDepartment of Cancer Biology and Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210; louise.fong@jefferson.edu carlo.croce@osumc.edu.
Thomas Jefferson University · USCancer Genetics (United States) · USUniversity of California, Davis · USOspedale di Parma · ITUniversity of Padua · IT

Funding

West Coast Central Comprehensive Metabolomics Resource Core (WC3MRC)U24DK097154 · NIDDK · UNIVERSITY OF CALIFORNIA AT DAVIS · PI FIEHN, OLIVER · 2012 to 2017
$9.9M
Cancer Gene Discovery to Identify Targetable TargetsR35CA197706 · NCI · OHIO STATE UNIVERSITY · PI CROCE, CARLO M · 2015 to 2021
$6.4M
Chemoprevention of upper aerodigestive tract cancer by dietary zincR01CA118560 · NCI · THOMAS JEFFERSON UNIVERSITY · PI FONG, LOUISE Y.Y. · 2006 to 2017
$2.7M
NCI NIH HHS R01 CA118560NCI NIH HHS R35 CA197706NIDDK NIH HHS U24 DK097154
6 · The paper itself

Abstract

MicroRNA-31 (miR-31) is overexpressed in esophageal squamous cell carcinoma (ESCC), a deadly disease associated with dietary Zn deficiency and inflammation. In a Zn deficiency-promoted rat ESCC model with miR-31 up-regulation, cancer-associated inflammation, and a high ESCC burden following

Indexed as

AnimalsCarcinogensCell Line, TumorDietary SupplementsEsophageal NeoplasmsEsophageal Squamous Cell CarcinomaEsophagusGene Expression Regulation, NeoplasticGene Knockout TechniquesHumansHypoxia-Inducible Factor-Proline DioxygenasesMaleMicroRNAsNeoplasms, ExperimentalNF-kappa BNitrosamines4-(N-nitroso-N-methylamino)butyric acidCarcinogensEGLN3 protein, humanEgln3 protein, ratHypoxia-Inducible Factor-Proline DioxygenasesMicroRNAsMIRN31 microRNA, humanMIRN31 microRNA, ratNF-kappa BNitrosaminesZincconstitutive miR-31 knockout ratesophageal cancer rat modelesophageal squamous cell carcinomain vivo antimiR-31 deliveryzinc deficiency

Identifiers

PMID32123074
PMCPMC7084137
OpenAlexW3009937264

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.